The market is segmented by age group into adults and pediatric. The adults phase accounted for optimum market income in 2018, and is anticipated to achieve dominance through the forecast interval owing to greater variety of sufferers affected by power ailments reminiscent of diabetes, most cancers, and gastrointestinal issues. Moreover, the rise in geriatric inhabitants that requires enteral vitamin and has problem in swallowing is predicted to contribute to the market progress.
Key Market Gamers
ABBOTT LABORATORIES
B. BRAUN MELSUNGEN AG
DANONE S.A.
FRESENIUS KABI AG
GLOBAL HEALTH PRODUCTS, INC.
HORMEL FOODS CORPORATION
MEIJI HOLDINGS CO., LTD.
NESTLE S.A
RECKITT BENCKISER GROUP PLC.
VICTUS, INC.
through the forecast interval, majorly owing to progress in prevalence of diabetes, most cancers & malnutrition instances and rise in geriatric inhabitants.
Comments
0 comments